Balaji Sugar Control

Avoid taking with alcohol or products that cause drowsiness. Reduce the dose or stop use if you experience abdominal pain, cramps, spasms, and/or diarrhea. Consult a health care practitioner before use if you have intestinal disorders, abdominal pain, nausea, fever, or vomiting. Consult a health care practitioner before use if you have kidney or liver disorders. If you have diabetes or are taking medication to control blood glucose levels, consult a health care practitioner prior to use. For prolonged use, consult a healthcare practitioner. Consult a healthcare practitioner/health care provider/health care professional/doctor/ physician if symptoms persist or worsen.

Contra-Indications:

Do not use if you are pregnant or breastfeeding, or if you are trying to conceive. Do not use if you have gastric disorders such as gallbladder disease, ulcers, gastritis.

Known Adverse Reactions:

Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. Stop use if hypersensitivity/allergy occurs. Diuretic effect may occur. Stop use if laxative effect occurs.

The following information is provided for educational purposes only. It does not represent health claims for this product and should not be taken as medical advice. Always consult a qualified health care practitioner before starting any new supplement.

Ingredients

• Ashwagandha (Withania somnifera): Reviews describe anti-inflammatory, cardioprotective and anti-diabetic properties; experimental work reports glucose-lowering in diabetes models and improvements in lipid profile and patient distress scores.
  
• Neem (Azadirachta indica): Systematic review/meta-analysis reports reductions in HbA1c, fasting and post-prandial glucose, and insulin resistance; reviews describe antidiabetic mechanisms involving flavonoids and terpenoids with antioxidant/anti-inflammatory actions and effects on insulin secretion/sensitivity.
  
• Dalchini / Cinnamon (Cinnamomum zeylanicum): Systematic review notes in-vivo effects including lower fasting glucose and HbA1c, improved lipids, and higher circulating insulin.
  
• Amla (Phyllanthus emblica): Reviews outline antidiabetic and antihyperlipidemic activities; in-vitro work shows inhibition of amylase/α-glucosidase and support for insulin signaling; animal data note lowered glucose and improved lipid markers.
  
• Baheda (Terminalia bellirica): Reported α-glucosidase inhibition and improvements in obesity-related and lipid parameters in animal models.
  
• Haritaki (Terminalia chebula): Demonstrates α-glucosidase inhibition, stimulation of insulin secretion/transport, and reductions in glucose and glycosylated hemoglobin in experimental studies.
  
• Gokhru / Tribulus terrestris: Reviews summarize antihypertensive, antihyperlipidemic, antioxidant, and traditional diuretic/urinary support properties.
  
• Gurmar (Gymnema sylvestre): Systematic reviews/meta-analyses report improvements in glycemic profile; mechanistic literature highlights gymnemic acids reducing intestinal glucose absorption, modulating taste receptors, and supporting insulin secretion/islet function.
  
• Bael (Aegle marmelos): Reviews detail phytochemicals (tannins, flavonoids, terpenoids, saponins) with antidiabetic effects, including β-cell support, enzyme inhibition, and increased glucose uptake in vitro and animal models.
  
• White Turmeric (Curcuma zedoaria): Essential-oil review describes sesquiterpenoid-rich profiles with anti-inflammatory, antioxidant and antimicrobial activities relevant to metabolic wellness contexts.
  
• Vijaysar (Pterocarpus marsupium): Literature notes heartwood/bark constituents (epicatechin, marsupsin, pterostilbene) associated with β-cell regeneration, insulin-like activity, and reduced blood glucose in experimental models; cell studies show enhanced glucose uptake.
  
• Swertia chirayita: Reviews cite antidiabetic and antioxidant properties; extracts lowered blood glucose in animal and in-vitro studies via flavonoids/secoiridoids.
  
• Fenugreek (Trigonella foenum-graecum): Human and animal studies report hypoglycemic and antihyperlipidemic effects, with compounds such as 4-hydroxyisoleucine supporting insulin secretion and improved glucose uptake.
  

References

Ahmad A, et al. (2022). Pterocarpus marsupium: pharmacognosy & anti-diabetic constituents. Plants, 11(3):247. https://doi.org/10.3390/plants11030247

Avalos-Soriano A, et al. (2016). 4-Hydroxyisoleucine from fenugreek & insulin resistance. Molecules, 21(11):1596. https://doi.org/10.3390/molecules21111596

Belapurkar P, et al. (2014). Immunomodulatory effects of triphala and constituents. Indian J Pharm Sci, 76(6):467–75. PMCID: PMC4293677

Chattopadhyay K, et al. (2022). Effectiveness & safety of Ayurvedic medicines in T2DM (meta-analysis). Front Pharmacol, 13:821810. https://doi.org/10.3389/fphar.2022.821810

Das G, et al. (2020). Plants of the genus Terminalia: clinical & preclinical insight. Front Pharmacol, 11:561248. https://doi.org/10.3389/fphar.2020.561248

Dar MI, et al. (2022). P. marsupium heartwood extract improves glucose uptake (HepG2). Metabolites, 12(10):947. https://doi.org/10.3390/metabo12100947

Devangan S, et al. (2021). G. sylvestre & glycemic control (systematic review). Phytother Res, 35(12):6802–6812. https://doi.org/10.1002/ptr.7265

Dey P, et al. (2020). Swertia chirayita extracts for diabetes & associated disorders. Nat Prod Bioprospect, 10(6):431–443. https://doi.org/10.1007/s13659-020-00277-7

Dosoky NS, Setzer WN. (2018). Curcuma species essential oils: composition & bioactivity. Nutrients, 10(9):1196. https://doi.org/10.3390/nu10091196

Gul M, et al. (2022). Nutraceutical significance of amla (review). Antioxidants, 11(5):816. https://doi.org/10.3390/antiox11050816

Jain S, et al. (2006). Standardised herbal extracts in type 1 diabetes (experimental). Afr J Tradit Complement Altern Med, 3(4):23–33.

Monika S, et al. (2023). Aegle marmelos: phytochemical & biological review. Future Sci OA, 9(3):FSO849. https://doi.org/10.2144/fsoa-2022-0068

Nagulapalli Venkata KC, et al. (2017). Fenugreek for disease prevention (review). Mol Nutr Food Res, 61(6):1600950. https://doi.org/10.1002/mnfr.201600950

Patil SM, et al. (2022). Neem against diabetes (review). J Pharm Pharmacol, 74(5):681–710. https://doi.org/10.1093/jpp/rgab098

Prananda AT, et al. (2023). P. emblica: phytochemistry & pharmacology (review). Front Pharmacol, 14:1288618. https://doi.org/10.3389/fphar.2023.1288618

Ranasinghe P, et al. (2013). ‘True’ cinnamon: medicinal properties (review). BMC Complement Altern Med, 13:275. https://doi.org/10.1186/1472-6882-13-275

Saeed M, et al. (2024). Phytopharmacology & traditional usage of Tribulus. Heliyon, 10(4):e25549. https://doi.org/10.1016/j.heliyon.2024.e25549

Saleem S, et al. (2018). Phytochemical profile & pharmacology of neem (review). Phytother Res, 32(7):1241–1272. https://doi.org/10.1002/ptr.6076

Sharma N, et al. (2022). A. marmelos: nutraceutical values (review). Int J Mol Sci, 23(18):10889. https://doi.org/10.3390/ijms231810889

Swati K, et al. (2023). Swertia chirayita: traditional uses & pharmacology. J Ethnopharmacol, 300:115714. https://doi.org/10.1016/j.jep.2022.115714

Wiciński M, et al. (2025). Ashwagandha and its effects on well-being (review). Nutrients, 17(13):2143. https://doi.org/10.3390/nu17132143

Yadav V, et al. (2020). Systematic review of Piper longum. J Ethnopharmacol, 247:112255. https://doi.org/10.1016/j.jep.2019.112255

Zamani M, et al. (2023). G. sylvestre effects on glycemia & lipids (meta-analysis). Phytother Res, 37(3):949–964. https://doi.org/10.1002/ptr.7585